Indeed, triglyceride infusion induces insulin resistance in both rodents [177] and humans [178], while systemic inhibition of triglyceride oxidation using etomoxir improves insulin sensitivity in skeletal muscle and adipose tissue [179,180]. Here, INS is linked to Insulin resistance.